Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Corman

Showing results (821-830 of 841) with videos related to

Pageof 85
Sort By:
Pathogens (Basel, Switzerland)|April 28, 2023
Monitoring the SARS-CoV-2 Pandemic: Prevalence of Antibodies in a Large, Repetitive Cross-Sectional Study of Blood Donors in Germany-Results from the SeBluCo Study 2020-2022Ruth Offergeld, Karina Preußel, Thomas Zeiler, et al.
Nature Neuroscience|December 1, 2020
Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19Jenny Meinhardt, Josefine Radke, Carsten Dittmayer, et al.
Nature|October 25, 2021
Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cellsMario Witkowski, Caroline Tizian, Marta Ferreira-Gomes, et al.
Infection|June 15, 2020
Studying the pathophysiology of coronavirus disease 2019: a protocol for the Berlin prospective COVID-19 patient cohort (Pa-COVID-19)Florian Kurth, Maria Roennefarth, Charlotte Thibeault, et al.
Plos Biology|November 16, 2022
SARS-CoV-2 variant Alpha has a spike-dependent replication advantage over the ancestral B.1 strain in human cells with low ACE2 expressionDaniela Niemeyer, Saskia Stenzel, Talitha Veith, et al.
Nature Communications|March 31, 2021
SARS-CoV-2 in severe COVID-19 induces a TGF-β-dominated chronic immune response that does not target itselfMarta Ferreira-Gomes, Andrey Kruglov, Pawel Durek, et al.
Nature Neuroscience|February 17, 2024
Proteomic and transcriptomic profiling of brainstem, cerebellum and olfactory tissues in early- and late-phase COVID-19Josefine Radke, Jenny Meinhardt, Tom Aschman, et al.
Science Translational Medicine|May 15, 2024
Comparative analysis of SARS-CoV-2 neutralization titers reveals consistency between human and animal model serum and across assaysBarbara Mühlemann, Samuel H Wilks, Lauren Baracco, et al.
Biorxiv : the Preprint Server for Biology|August 21, 2020
A SARS-CoV-2 neutralizing antibody protects from lung pathology in a COVID-19 hamster modelJakob Kreye, S Momsen Reincke, Hans-Christian Kornau, et al.
Biorxiv : the Preprint Server for Biology|October 9, 2023
Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model SeraBarbara Mühlemann, Samuel H Wilks, Lauren Baracco, et al.
Pageof 85

Showing results (821-830 of 841) with videos related to

Sort By:
Pageof 85
Pathogens (Basel, Switzerland)|April 28, 2023
Monitoring the SARS-CoV-2 Pandemic: Prevalence of Antibodies in a Large, Repetitive Cross-Sectional Study of Blood Donors in Germany-Results from the SeBluCo Study 2020-2022Ruth Offergeld, Karina Preußel, Thomas Zeiler, et al.
Nature Neuroscience|December 1, 2020
Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19Jenny Meinhardt, Josefine Radke, Carsten Dittmayer, et al.
Nature|October 25, 2021
Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cellsMario Witkowski, Caroline Tizian, Marta Ferreira-Gomes, et al.
Infection|June 15, 2020
Studying the pathophysiology of coronavirus disease 2019: a protocol for the Berlin prospective COVID-19 patient cohort (Pa-COVID-19)Florian Kurth, Maria Roennefarth, Charlotte Thibeault, et al.
Plos Biology|November 16, 2022
SARS-CoV-2 variant Alpha has a spike-dependent replication advantage over the ancestral B.1 strain in human cells with low ACE2 expressionDaniela Niemeyer, Saskia Stenzel, Talitha Veith, et al.
Nature Communications|March 31, 2021
SARS-CoV-2 in severe COVID-19 induces a TGF-β-dominated chronic immune response that does not target itselfMarta Ferreira-Gomes, Andrey Kruglov, Pawel Durek, et al.
Nature Neuroscience|February 17, 2024
Proteomic and transcriptomic profiling of brainstem, cerebellum and olfactory tissues in early- and late-phase COVID-19Josefine Radke, Jenny Meinhardt, Tom Aschman, et al.
Science Translational Medicine|May 15, 2024
Comparative analysis of SARS-CoV-2 neutralization titers reveals consistency between human and animal model serum and across assaysBarbara Mühlemann, Samuel H Wilks, Lauren Baracco, et al.
Biorxiv : the Preprint Server for Biology|August 21, 2020
A SARS-CoV-2 neutralizing antibody protects from lung pathology in a COVID-19 hamster modelJakob Kreye, S Momsen Reincke, Hans-Christian Kornau, et al.
Biorxiv : the Preprint Server for Biology|October 9, 2023
Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model SeraBarbara Mühlemann, Samuel H Wilks, Lauren Baracco, et al.
Pageof 85